Showing results (11-20 of 28) with videos related to
Sort By:
Pageof 3
Psychology of Addictive Behaviors : Journal of the Society of Psychologists in Addictive Behaviors|July 18, 2017
Pilot investigation of a phosphatidylethanol-based contingency management intervention targeting alcohol useMichael G McDonell, Jordan Skalisky, Emily Leickly, et al.Brain and Behavior|July 15, 2023
Impaired aldehyde detoxification exacerbates motor deficits in an alpha-synuclein mouse model of Parkinson's diseasePaul Anthony Martinez, Vanessa Elia Martinez, Sheela Rani, et al.The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences|March 21, 2026
Chronic rapamycin treatment attenuates age-related motor deficits in sex-dependent manner in UM-HET3 miceRashmi Singh, Vanessa Elia Calderon, Holstein Deborah, et al.Pathobiology of Aging & Age Related Diseases|May 31, 2016
Adaptations to chronic rapamycin in miceSherry G Dodds, Carolina B Livi, Manish Parihar, et al.Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|May 18, 2017
mTOR drives cerebral blood flow and memory deficits in LDLR<sup>-/-</sup> mice modeling atherosclerosis and vascular cognitive impairmentJordan B Jahrling, Ai-Ling Lin, Nicholas DeRosa, et al.Contemporary Clinical Trials Communications|March 25, 2021
Mixed-methods trial of a phosphatidylethanol-based contingency management intervention to initiate and maintain alcohol abstinence in formerly homeless adults with alcohol use disordersElizabeth R Fraser, Nathalie Hill-Kapturczak, Julianne Jett, et al.Plos One|January 11, 2014
Mice fed rapamycin have an increase in lifespan associated with major changes in the liver transcriptomeWilson C Fok, Yidong Chen, Alex Bokov, et al.Aging Cell|December 6, 2013
Combined treatment of rapamycin and dietary restriction has a larger effect on the transcriptome and metabolome of liverWilson C Fok, Alex Bokov, Jonathan Gelfond, et al.Journal for Immunotherapy of Cancer|March 3, 2021
Rapamycin enhances BCG-specific γδ T cells during intravesical BCG therapy for non-muscle invasive bladder cancer: a randomized, double-blind studyNiannian Ji, Neelam Mukherjee, Ryan M Reyes, et al.Cancer Prevention Research (Philadelphia, Pa.)|November 28, 2013
eRapa restores a normal life span in a FAP mouse modelPaul Hasty, Carolina B Livi, Sherry G Dodds, et al.Pageof 3